Two large clinical trials in Africa are ramping up to test the effectiveness of a vaginal ring that releases an HIV-fighting drug for a month or more, offering…

A study of black gay and bisexual men in six U.S. cities found HIV infection rates that were 50 percent higher than among their white counterparts,…

The World Health Organization has endorsed using HIV medicines among people who do not have the infection but are at high risk of getting it and suggested that poor…

An international health panel has recommended for the first time that all HIV patients be treated with antiretroviral drugs, even when the virus’s impact on their immune system is…

Infection with both of the major subtypes of HIV at the same time slows the progression of disease, researchers reported.

In a long-running cohort study, people co-infected with both HIV-1 and HIV-2…

Fewer people infected with HIV globally are dying as more of them get access to crucial antiretroviral drugs, particularly in sub-Saharan Africa, the United Nations AIDS program said…

At an ill-fated press conference in 1984, U.S. Health and Human Services Secretary Margaret Heckler boldly predicted an effective AIDS vaccine would be available within just two years.

But…

A cohort of HIV-infected women had no cases of histologically confirmed high-risk cervical neoplasia during follow-up after negative cotesting for human papillomavirus (HPV) infection, investigators reported.

Of 245 patients with paired…

Shares of OraSure Technologies Inc rose to their highest in more than 10 years after U.S. health regulators on Tuesday approved its in-home HIV test, the first…

Mike Godfrey was 19 when he found out he had HIV.

He was 29 when he began antiretroviral therapy.

He was 43 when he had a heart attack.

“I…

In the battle against HIV/AIDS conditions on the frontlines are constantly in flux as treatment, research and policy evolve.  The landmark HIV Prevention Trials Network (HPTN) 052…

Drug maker Gilead Sciences Inc says federal health regulators have delayed a decision on whether to approve its drug Truvada as the first pill that prevents HIV infection.

Human immunodeficiency virus (HIV) superinfection may be as common as initial HIV infection and is not limited to high risk-populations, according to a new study led…

HIV superinfection, when a person with HIV could acquire a second, new strain of HIV, may occur as often as initial HIV infection in…

Millions of the world’s poorest people could have easier access to life-saving drugs if India introduces an air ticket tax to help fund purchases of…

While immediate postexposure treatment for suspected HIV is critical, pre-exposure preventive treatment is a newer method that may be effective for people in high-risk groups, states…

Americans are a step closer to being able to quickly determine in the privacy of their own homes whether they’re infected with HIV, the virus that causes AIDS.

An…

An FDA Advisory Panel unanimously recommended the approval of a new in-Home HIV Test yesterday afternoon. Local advocates are happy another weapon will be available in the fight against HIV.

“This…

A federal advisory committee on Tuesday unanimously approved over-the-counter sale of a rapid HIV test, acknowledging the need for new tools against an epidemic that is driven largely by people who don’t know…

WASHINGTON, D.C., May 11, 2012 - Who’s Positive, a national HIV awareness organization, today announced the results of a year-long online survey measuring support for over-the counter (OTC) HIV…

An advisory panel to the Food and Drug Administration is expected to vote Thursday on whether a drug already used to treat H.I.V. infection should also be approved to…

UC Davis Health System researchers are a step closer to launching human clinical trials involving the use of an innovative stem cell therapy to fight the virus that…

In a groundbreaking study published last year, scientists reported that effective treatment with HIV medications not only restores health and prolongs life in many HIV-infected patients, but also curtails…

California will test an HIV-prevention pill in an attempt to slow the spread of the disease in the state, researchers announced Tuesday.

The pill, which is already used to treat…

A new understanding of the initial interactions of human immunodeficiency virus type 1 (HIV-1) and dendritic cells is described by Boston University School of Medicine (BUSM) researchers…